Delivery Order SPE2DR25D2009-SPE2DR26FJ4A1
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $3,549.72 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on December 19, 2025, for the supply of Qualiptä 60 mg tablets (30-count packaging). The delivery order, which represents a non-competitive award under an existing contract vehicle, is scheduled for completion by December 22, 2025. This award falls under AmerisourceBergen's broader relationship with the DLA as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $72,974.58 by the Defense Logistics Agency's Medical Supply Chain. The competitive award, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, carries a firm fixed price structure with no set-aside designation. This delivery order operates as a child contract under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $57,029.60 by the Defense Logistics Agency's Medical Supply Chain. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $363,092.52 by the Defense Logistics Agency's Medical Supply Chain on December 29, 2025. This firm fixed-price delivery order, which is a child contract under a larger vehicle, carries an ultimate completion date of December 30, 2025. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $30,699.70 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain. The award, issued on December 29, 2025, represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 30, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $2,292.48 by the Defense Logistics Agency's Medical Supply Chain on November 24, 2025, with a completion date of November 25, 2025. This firm fixed-price delivery order is a non-set-aside competitive award issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $55,577.40 by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $66,182.76 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 2, 2025. This contract is issued on a firm fixed-price basis with no set-aside designation, indicating it was awarded through open competition. The delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,361.72 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with a completion date of December 2, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,093.88 by the Defense Logistics Agency's Medical Supply Chain on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4A1Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,551.70 by the Defense Logistics Agency on December 9, 2025, for the supply of Qualiptá 60 mg tablets in a quantity of 30 units. This firm fixed price delivery order, with an ultimate completion date of December 10, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's Conshohocken facility. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal procurement portfolio demonstrates extensive capability in fulfilling Defense Logistics Agency medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines. The company's track record of competitively awarded delivery orders, ranging from nominal values to orders exceeding $45,000, and its designation as a prime vendor under DLA's Pharmaceutical Prime Vendor Global Program, position it as a critical supplier to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This particular delivery order exemplifies the company's role in supporting military medical operations through the robust IDC framework established with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/8/25 |